Evidence map›Paper›PMID 30445673›Full record

ArticleInternational journal of molecular sciences2018

Design of a 3D BMP-2-Delivering Tannylated PCL Scaffold and Its Anti-Oxidant, Anti-Inflammatory, and Osteogenic Effects In Vitro.

Jae Yong Lee, Hyunwoong Lim, Jae Won Ahn, Dongsik Jang, Seung Hee Lee, Kyeongsoon Park, Sung Eun Kim

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Jae Yong LeeDepartment of Orthopedic Surgery and Rare Diseases Institute, Korea University Guro Hospital, Korea University College of Medicine, 148 Guro-dong, Guro-gu, Seoul 08308, Korea. bulegir@nate.com.
Hyunwoong LimDepartment of Industrial Management Engineering, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Korea. limhw@korea.ac.kr.
Jae Won AhnDepartment of Systems Biotechnology, Chung-Ang University, Anseong, Gyeonggi-do 17546, Korea. pinkymonkey1@naver.com.
Dongsik JangDepartment of Industrial Management Engineering, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Korea. Jang@korea.ac.kr.
Seung Hee LeeDepartment of Nursing, Inha University, 100 Inha-ro, Michuhol-gu, Incheon 22212, Korea. freelovein@hanmail.net.
Kyeongsoon ParkDepartment of Systems Biotechnology, Chung-Ang University, Anseong, Gyeonggi-do 17546, Korea. kspark1223@cau.ac.kr.ORCID 0000-0003-3625-4128
Sung Eun KimDepartment of Orthopedic Surgery and Rare Diseases Institute, Korea University Guro Hospital, Korea University College of Medicine, 148 Guro-dong, Guro-gu, Seoul 08308, Korea. sekim10@korea.ac.kr.
Chung-Ang University · KRKorea University · KRKorea University Medical Center · KRInha University · KR

Funding

Chung-Ang University Research Scholarship Grants 2017
6 · The paper itself

Abstract

In this study, a novel three-dimensional (3D) bone morphogenic protein-2 (BMP-2)-delivering tannylated polycaprolactone (PCL) (BMP-2/tannic acid (TA)/PCL) scaffold with anti-oxidant, anti-inflammatory, and osteogenic activities was fabricated via simple surface coating with TA, followed by the immobilization of BMP-2 on the TA-coated PCL scaffold. The BMP-2/TA/PCL scaffold showed controlled and sustained BMP-2 release. It effectively scavenged reactive oxygen species (ROS) in cells, and increased the proliferation of MC3T3-E1 cells pre-treated with hydrogen peroxide (H₂O₂). Additionally, the BMP-2/TA/PCL scaffold significantly suppressed the mRNA levels of pro-inflammatory cytokines, including matrix metalloproteinases-3 (MMP-3), cyclooxygenase-2 (COX-2), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α), in lipopolysaccharide (LPS)-induced MC3T3-E1 cells. Furthermore, it showed outstanding enhancement of the osteogenic activity of MC3T3-E1 cells through increased alkaline phosphatase (ALP) activity and calcium deposition. Our findings demonstrated that the BMP-2/TA/PCL scaffold plays an important role in scavenging ROS, suppressing inflammatory response, and enhancing the osteogenic differentiation of cells.

Indexed as

Alkaline PhosphataseAnimalsAnti-Inflammatory AgentsAntioxidantsBone Morphogenetic Protein 2CalciumCell LineCell SurvivalDrug LiberationLipopolysaccharidesMiceOsteogenesisPhotoelectron SpectroscopyPolyestersReactive Oxygen SpeciesRNA, MessengerAlkaline PhosphataseAnti-Inflammatory AgentsAntioxidantsBone Morphogenetic Protein 2CalciumLipopolysaccharidespolycaprolactonePolyestersReactive Oxygen SpeciesRNA, MessengerTannins3D scaffoldanti-inflammationanti-oxidationbone morphogenic protein-2 (BMP-2)osteogenic differentiationpolycaprolactone (PCL)tannic acid (TA)

Identifiers

PMID30445673
PMCPMC6274927
OpenAlexW2901189769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.